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Abstract
Background: To investigate the correlation and level of agreement between end-tidal carbon
dioxide (EtCO2) and blood gas pCO2  in non-intubated children with moderate to severe
respiratory distress.
Methods: Retrospective study of patients admitted to an intermediate care unit (InCU) at a
tertiary care center over a 20-month period with moderate to severe respiratory distress
secondary to asthma, bronchiolitis, or pneumonia. Patients with venous pCO2 (vpCO2) and EtCO2
measurements within 10 minutes of each other were eligible for inclusion. Patients with cardiac
disease, chronic pulmonary disease, poor tissue perfusion, or metabolic abnormalities were
excluded.
Results: Eighty EtCO2-vpCO2 paired values were available from 62 patients. The mean ± SD for
EtCO2 and vpCO2 was 35.7 ± 10.1 mmHg and 39.4 ± 10.9 mmHg respectively. EtCO2 and vpCO2
values were highly correlated (r = 0.90, p < 0.0001). The correlations for asthma, bronchiolitis and
pneumonia were 0.74 (p < 0.0001), 0.83 (p = 0.0002) and 0.98 (p < 0.0001) respectively. The mean
bias ± SD between EtCO2 and vpCO2 was -3.68 ± 4.70 mmHg. The 95% level of agreement ranged
from -12.88 to +5.53 mmHg. EtCO2 was found to be more accurate when vpCO2 was 35 mmHg
or lower.
Conclusion: EtCO2 is correlated highly with vpCO2 in non-intubated pediatric patients with
moderate to severe respiratory distress across respiratory illnesses. Although the level of
agreement between the two methods precludes the overall replacement of blood gas evaluation,
EtCO2 monitoring remains a useful, continuous, non-invasive measure in the management of non-
intubated children with moderate to severe respiratory distress.
Background
With the advent of capnography, physicians have been
given a tool to non-invasively assess the ventilatory status
of their patients. This has had far reaching implications in
patient care. End-tidal CO2 (EtCO2) measurement has
become standard for clinical monitoring of both adult
and pediatric patients undergoing general anesthesia, and
has proven to be useful in a variety of other clinical set-
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tings.[1,2] In the pre-clinical setting, EtCO2 monitoring
has been standard of care for patients requiring cardiopul-
monary resuscitation and emergency cardiovascular care
since 2000. [3-5] In both pediatric intensive care unit
(PICU) and emergency department (ED) settings, capnog-
raphy is now widely used to confirm appropriate endotra-
cheal tube placement and for the continuous
management of mechanical ventilation. [6-8] EtCO2
monitoring is also useful in identifying apnea and bron-
chospasm in non-intubated children undergoing proce-
dural sedation [9-13] and in assessing the degree of
metabolic acidosis in various pediatric populations. [14-
17]
Though EtCO2 monitoring has proven to be efficacious in
diverse clinical areas, its utility in non-intubated patients
with pulmonary disease remains undefined. In patients
with significant pulmonary disease, it is generally believed
that EtCO2 values will not accurately reflect blood gas
pCO2  because of ventilation-perfusion mismatch,
increased dead space, and/or increased shunt fraction.
[18-21] In fact, a number of studies have demonstrated
the inaccuracy of capnography in intubated and non-intu-
bated patients with pulmonary disease.[20,22-25] How-
ever, most of these studies focused on patients with severe
lung disease or used technology that is now considered
out of date.
Because of the general assumption that EtCO2 monitoring
is less accurate in patients with pulmonary disease, there
is a paucity of data assessing its utility as a corollary to
blood gas pCO2 in non-intubated pediatric patients with
moderate to severe respiratory distress. In this study, we
investigated the association of EtCO2 to vpCO2 in hospi-
talized non-intubated children with moderate to severe
respiratory distress secondary to asthma, bronchiolitis, or
pneumonia. We also examined the level of agreement
between vpCO2 and EtCO2 to determine if EtCO2 could
replace blood gas evaluation in the management of non-
intubated pediatric patients with respiratory distress sec-
ondary to a pulmonary process.
Methods
We performed a retrospective chart review of pediatric
patients admitted with moderate to severe respiratory dis-
tress secondary to asthma, bronchiolitis, or pneumonia to
the intermediate care unit (InCU) at Children's Hospital
Boston (CHB) between July, 2003-February, 2005. The
InCU is designed for patients who are moderately to criti-
cally ill, who need close monitoring and increased nurs-
ing needs, but who do not need invasive monitoring,
acute ventilatory support, or vasopressor therapy. Contin-
uous nasal cannula EtCO2 monitoring is standard of care
for all patients admitted to the InCU with respiratory dis-
tress. The study was approved by the institutional review
board of CHB.
All patients admitted to the InCU with moderate to severe
respiratory distress secondary to above diagnoses and who
had a blood gas evaluation and an EtCO2 measurement
within 10 minutes of each other were eligible for inclu-
sion. Moderate to severe respiratory distress was defined
as tachypnea and oxygen saturation < 94% on room air
with retractions and decreased aeration on physical exam-
ination. Patients with chronic pulmonary disease (cystic
fibrosis, chronic lung disease), cardiac disease, poor tissue
perfusion (defined as capillary refill greater than 2 sec-
onds), or underlying metabolic abnormalities were also
excluded. Patients undergoing acute respiratory failure
defined as immediate subsequent transfer from the InCU
to the intensive care unit for invasive respiratory support
were also excluded.
Data collected on each patient included patient demo-
graphics, vitals measurements, and O2  requirement at
time of EtCO2 reading. The patients' pulmonary status
including severity of retractions and level of aeration as
recorded by InCU nurses on InCU data tracking flowsheet
were also included. Retractions and aeration were meas-
ured on a scale ranging from 0 (no retractions, normal
aeration, respectively) to 3 (significant subcostal and
suprasternal retractions, severely decreased aeration
throughout lung fields, respectively). EtCO2 values were
measured using Microstream® Capnoline™ H nasal can-
nula (Oridion Medical, Jerusalem, Israel) attached to
Invivo MDE Escort Prism®  monitors (Invivo MDE,
Orlando FL, USA).
Statistical Analysis
The association between EtCO2 and vpCO2 values was
analyzed using the Pearson product-moment correlation
coefficient (r) and simple linear regression. Multivariate
linear regression was used to assess for variation in bias
between EtCO2  and vpCO2  according to clinical and
patient characteristics. Bland-Altman analysis was per-
formed to determine the level of agreement between
EtCO2 and vpCO2 values.[26,27] We also compared the
linear regression between EtCO2 and vpCO2 to the line of
unity between the two measurements to further define the
relationship between EtCO2 and vpCO2. Statistical analy-
sis was performed using SAS Version 9.1 (SAS Institute
Inc., Cary, NC, USA).
Results
There were 80 paired EtCO2-vpCO2  values from 62
patients. 40 of the 80 paired measurements were simulta-
neous. The mean ± SD time difference between measure-
ments was 0.67 ± 8.19 minutes. The bias between EtCO2-BMC Pediatrics 2009, 9:20 http://www.biomedcentral.com/1471-2431/9/20
Page 3 of 6
(page number not for citation purposes)
vpCO2 values was not significantly affected by the time
difference between measurements (p = 0.6110).
Age ranged from 5.5 months-20 years with a median age
of 5.7 years. Asthma was the admitting diagnosis for 41
patients, bronchiolitis for 9 patients and pneumonia for
12 patients. Other characteristics of our study sample are
included in Table 1.
The mean ± SD for EtCO2 and vpCO2 was 35.7 ± 10.1
mmHg and 39.4 ± 10.9 mmHg respectively. EtCO2 and
vpCO2 were highly correlated (r = 0.90, p < 0.0001). As
shown in Figure 1, the correlations for asthma, bronchi-
olitis and pneumonia were 0.74 (p < 0.0001), 0.83 (p =
0.0002) and 0.98 (p < 0.0001) respectively.
The mean bias ± SD between EtCO2 and vpCO2 values
from the Bland-Altman analysis (Figure 2) was -3.68 ±
4.70 mmHg. The 95% limits of agreement between EtCO2
and vpCO2 ranged from -12.88 to +5.53 mmHg. EtCO2
was within ± 5 mmHg of vpCO2 in 46 of the 80 values and
within ± 10 mmHg of vpCO2 in 73 of the 80 values. Bias
did not significantly vary across the range of averaged val-
ues. From multivariate regression, the bias between EtCO2
and vpCO2 did not vary according to age (p = 0.8445), res-
piratory rate (p = .9305), oxygen requirement (p =
0.4222), or clinical assessment measurements such as aer-
ation (p = 0.3876) or retractions (p = 0.4381).
Further analysis was conducted in order to identify the
range of EtCO2 values in which accuracy would be maxi-
mized in relation to vpCO2. Figure 3 illustrates the regres-
sion of EtCO2 and vpCO2, which deviated significantly
from the line of unity (F(2,78) = 35.5, p < 0.001). The
regression line and the line of unity were within 3 mmHg
of each other for vpCO2 values under 35 mmHg but
parted increasingly in the higher range, differing by 5
mmHg above vpCO2 of 47 mmHg. This suggests that max-
imum EtCO2  accuracy is achieved when vpCO2  is 35
mmHg or below.
Discussion
The utility of EtCO2 monitoring in the assessment and
management of non-intubated pediatric patients with
moderate to severe respiratory distress has remained
largely undefined. Historically, studies have found EtCO2
Table 1: Characteristics of Study Sample (n = 62)
Age, median (range), years 5.7 (0.047–20.09)
Diagnosis, n (%)
Asthma 41 (66)
Bronchiolitis 9 (15)
Pneumonia 12 (29)
RR, mean ± SD, breaths/min 38.3 ± 18.6
Supplemental O2 requirement, n (%)
Room air 13 (21)
O2 req. 45 (72)
Not recorded 4 (6)
Disposition, n (%)
Home 9 (15)
General Floor 44 (71)
ICU 7 (11)
Other 2 (3)
EtCO2, mean ± SD, mm Hg 35.7 ± 10.1
vpCO2, mean (± SD), mm Hg 39.4 ± 10.9
EtCO2 vs. vpCO2 by Admitting Diagnosis Figure 1
EtCO2 vs. vpCO2 by Admitting Diagnosis.
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monitoring to have limited accuracy in both intubated
and non-intubated patients with pulmonary dis-
ease.[20,22-25] Because of these prior studies most physi-
cians agree that in the clinical setting of respiratory
distress, EtCO2 monitoring is mostly useful in following
the trend in ventilatory status and not as a specific corre-
late to blood gas pCO2.[23,28] However, knowing EtCO2
can serve as a direct corollary to blood gas pCO2  in
patients without pulmonary disease[22,25,29], it raises
the question of a possible threshold of pulmonary disease
that until reached EtCO2  remains an accurate tool to
assess blood gas pCO2.
In this study, we found EtCO2 to be highly correlated with
venous pCO2 and that this relationship was significant
across the range of common respiratory illnesses that
cause moderate to severe respiratory distress in children.
Only one prior study has evaluated the accuracy of non-
invasive capnography in non-intubated pediatric patients
with respiratory distress.[30] Abramo et al compared a
single EtCO2 value to capillary pCO2 in pediatrics patients
presenting to the emergency department with respiratory
emergencies. Their study also found a high correlation
between EtCO2 and blood gas pCO2. (r = 0.87, p= <
0.0001).
Important differences between this prior study and our
current study exist. Specifically, there were differences in
the severity and underlying causes of respiratory distress
in the study populations. 73% of study participants in the
prior study were discharged home from the emergency
department and the study included patients with signs of
upper airway obstruction that may not have had any
direct pulmonary involvement. In our study, patients
were admitted with moderate to severe respiratory distress
secondary to significant lower tract disease. All patients
were determined by the admitting physician not to be safe
for floor management and therefore admitted to the
InCU. Even in this setting, EtCO2 was still highly corre-
lated to blood gas pCO2 and EtCO2 monitoring proved
useful in the clinical management of the patients beyond
just 'following the trend.'
One of the main objectives of our study was to determine
if EtCO2 can replace blood gas pCO2 in the management
of non-intubated pediatric patients with moderate to
severe respiratory distress. This decision should be based
on the level of agreement between the two methods.[26]
Though we found high correlation between EtCO2 and
venous pCO2, correlation is not a measure of agreement
but instead is a measure of association. Perfect agreement
exists between two methods only when pairs of measure-
ments lie along their line of unity with a slope of 1 and an
intercept of 0. Conversely, perfect correlation between
two methods exists when pairs of measurements approxi-
mate any straight line.[27] For example, if two different
scales measuring body weight in kilograms always dif-
fered by 20, the two scales would be highly correlated to
one another but their level of agreement would be low.
High correlation can therefore conceal a significant lack of
agreement. Consequently, agreement not correlation
determines if one method can replace the other.
The Bland-Altman analysis allows for an overall assess-
ment of agreement between two methods. From the
Bland-Altman analysis, the bias ± SD between EtCO2 and
vpCO2 in our study was -3.68 ± 4.70 mmHg. This bias did
not vary across the averaged values of EtCO2 and vpCO2.
Abramo et al[30] found a comparable bias between capil-
lary CO2 and EtCO2 of 3.2 ± 2.4 mmHg. Physiologically,
there exists a difference between ideally measured EtCO2
concentration and blood gas pCO2, whether arterial or
venous. Assuming a difference between arterial and
mixed-venous pCO2 of 2–5 mmHg[31] one would expect
at least a 2–5 mmHg difference between EtCO2  and
venous pCO2. Therefore, the observed mean difference of
-3.68 closely approximates the true physiologic differ-
ence.
The 95% limits of agreement between EtCO2 and vpCO2
ranged from -12.88 to +5.53 mmHg. This range of EtCO2
values is clinically too imprecise for EtCO2 to replace
vpCO2 in the clinical management of patients with respi-
ratory distress. However, knowing the range of EtCO2 val-
ues can inform clinical decisions in regards to the
management of these patients.
Regression of EtCO2 and vpCO2 Values with Line of Unity Figure 3
Regression of EtCO2 and vpCO2 Values with Line of 
Unity. The equation for the regression line is EtCO2 = 
.832904(vpCO2) + 2.905448, r2 = 0.8161.BMC Pediatrics 2009, 9:20 http://www.biomedcentral.com/1471-2431/9/20
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In an effort to further define the ability of EtCO2 to accu-
rately reflect the true value of vpCO2, we found on further
analysis that the regression line of EtCO2 in Figure 3 was
within 2–3 mmHg of the line of unity between EtCO2 and
vpCO2 measurements when vpCO2 was below 35 mmHg.
At higher vpCO2 values, EtCO2 was not as accurate. There-
fore, for values of vpCO2 of 35 mmHg or less, EtCO2 may
have an acceptable level of accuracy to serve as indirect
measurement of vpCO2  and thereby be a therapeutic
guide.
Our study has several limitations. First, no prior study has
used venous pCO2 in assessing the accuracy of EtCO2 to
reflect blood gas pCO2 content. Venous pCO2 levels reflect
many factors beyond just the ventilatory status of the
patient including global oxygen consumption, O2 deliv-
ery, tissue perfusion, level of metabolic acidosis, and
hypoxia.[32] Therefore, venous pCO2 is not regarded as
the gold standard to which EtCO2 should be compared.
The use of venous pCO2 in this study was determined
mainly by our patient population. Arterial blood gas eval-
uations in non-intubated pediatric patients are only per-
formed when absolutely necessary secondary to their
invasive nature, risk of complication, and high level of
pain associated with the procedure.[33,34] In the pediat-
ric population, repeat arterial blood gas evaluations tend
to be limited to PICU settings in which patients are intu-
bated and sedated. Venous blood gases are therefore more
relied upon in assessing the respiratory status of patients
in the general pediatric population. Of note, studies com-
paring venous pCO2 and arterial pCO2 have found a high
level of correlation and agreement between the two meas-
ures, especially in patients who have good tissue per-
fusion. [35-37] The patient population in this study was
limited to those patients without signs of vascular com-
promise or metabolic disease in order to ensure that the
venous pCO2 values would most accurately reflect the
ventilatory status of the patient. Furthermore, by using
venous samples for blood gas pCO2 measurement we feel
that our study more accurately reflects current practice
patterns in the management of pediatrics patients with
respiratory distress who are not receiving sedation for
invasive ventilatory support
Another limitation of our study was the timing of meas-
urements. Though most evaluations of EtCO2 and blood
gas pCO2 were recorded as simultaneous, a number of
paired values were not done instantaneously. We limited
the time difference between the two measurements to 10
minutes for inclusion in our study. Under ideal circum-
stances, blood gas evaluations and EtCO2 measurements
should be done simultaneously because of the minute to
minute fluctuations in CO2 levels. A final limitation of the
study was its retrospective nature which may have intro-
duced bias.
Despite these several limitations, we still demonstrated a
high correlation and moderate amount of agreement
between both vpCO2 and EtCO2. We have also further
defined the role of EtCO2 in the management of non-intu-
bated pediatric patients with moderate to severe respira-
tory distress.
Conclusion
This study demonstrates the utility of EtCO2 as a correlate
to vpCO2 in the clinical assessment of pediatric patients
with moderate to severe respiratory distress. Though
EtCO2 monitoring does not replace blood gas assessment
it can serve as an important adjunct in the clinical man-
agement of pediatric patients even with significant pul-
monary disease. Further study should continue to define
the utility of EtCO2 as a measure of blood gas pCO2 in
pediatrics patients with moderate to severe respiratory dis-
tress.
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